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Supplementary Figures
  
 
Figure S1. Characterization of brain hydrogel peptide incorporation and modulus. a) Spectra of adhesive 
and b) degradable peptides as identified via MALDI-TOF analysis. c) Peaks corresponding to the different 
amino acid sequences in the mixture. d) Analysis of brain hydrogel supernatant after polymerization was 
performed for 10 minutes shows no peaks. e) Modulus of hydrogels as a function of the weight % of PEG-
maleimide included. 
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Figure S2. Adhesion of human cell lines to integrin-binding peptides in the brain hydrogel formulation. 
Human cell lines a) SK-N-AS (neuroblast) and b) MDA-MB-231-BrM2a (brain-metastatic breast cancer) 
were seeded in surfaces functionalized with poly(ethylene)glycol (PEG) (gray), brain integrin-binding 
peptides (maroon), or previously incubated with the brain integrin-binding peptide cocktail (green) and then 
seeded into a coverslip functionalized with the same peptide mixture. Cell area was traced every five 
minutes for a period of 120 (a) or 100 minutes (b). Cell area increased significantly in the non-treated 
(maroon) cells that were seeded directly onto coverslips with the adhesive peptide mixture, while the cell 
area remained small in the PEG condition. Cells treated with the adhesive peptide mixture for five minutes 
prior to seeding onto coverslips took longer to increase the cell area. Data shown is mean (solid line) + s.d. 
(shade region). N=2, n=30.  c) SK-N-AS and d) MDA-MB-231-BrM2a cells were seeded into coverslips 
functionalized with each integrin-binding peptide for a period of 2 hours. Cells were washed, fixed and 
stained with DAPI and counted with ImageJ software. Data shown is the number of cells attached 
normalized to PEG as mean + s.d. N=2, n=3. e) Representative images of SK-N-AS and f) MDA-MB-231-
BrM2a cells adhering overtime to coverslips functionalized with the integrin-binding peptide mixture or PEG. 
Cells show a larger area when cultured on coverslips functionalized with the adhesive peptide mixture in 
contrast to PEG alone. 
 
 
 
 
 
  
 
 
Figure S3. Analysis of mouse cell adhesion to human brain peptides and comparative sequence homology. 
a) Quantification of cell area traces overtime for the murine cell lines Neuro2A and b) mHippoE18. Cells 
were seeded onto coverslips functionalized with poly(ethylene)glycol (PEG) (gray), the brain integrin-
binding ECM peptides (maroon), or incubated for five minutes with the integrin-binding brain peptides 
followed by seeding onto coverslips functionalized with the same integrin-binding peptides (green). Data 
shown is mean (solid line) +/- s.d. (shaded area). N=2, n=30. c) Cell lines Neuro2A (mouse neuroblastoma) 
and d) mHippoE18 (mouse embryonic hippocampus) were seeded into coverslips functionalized with each 
integrin-binding peptide and allowed to adhere for 2 hours. Change in cell area from directly after seeding 
up to 2 hours are shown for each integrin-binding peptide, PEG, and the brain integrin-binding peptide 
mixture. e) Neuro2A and f) mHippoE18 representative images of cell spreading on coverslips functionalized 
with PEG or the brain integrin-binding ECM mixture over 2 hours. g) Competitive binding of the human cell 
line SK-N-AS and h) murine cell line Neuro2A. Cells were previously incubated for five minutes in the 
peptide of interest in soluble form and subsequently seeded into a coverslip functionalized with the integrin-
binding peptide mixture. Data shown is mean + s.e.m. N=2, n=30. i) Sequences that did not inhibit cell 
adhesion of the Neuro2A cell line to the integrin-binding peptide mixture functionalized coverslip are not 
found in the protein sequence of the mouse.  
 
 
 
 
 Figure S4. Validation of integrin localization at cell membrane after encapsulation. a) Human primary 
astrocytes were encapsulated for five minutes in collagen or hydrogels modified with a single integrin-
binding peptide at the same concentration as in the brain adhesive peptide mixture, b) or negative control 
poly(ethylene)glycol hydrogels without integrin-binding peptides. Hydrogels were fixed and stained for the 
expected integrin subunits (colors in the text inset for each integrin subunit) known to bind with their 
heterodimer partners to the peptides in the gel (See Tables S2-3 for full list). Membrane stain (red) and 
DAPI (blue) were also included for visualization purposes. Omitted images are from unreliable antibodies 
found for human integrin subunits (not suitable for immunofluorescence). 
 
 
 
 
 
 
 
 
 
 
Collagen RGDVTCG YIGSRIVRRADRAVPIKVAV DGEA FYFDLR EIDGIEL ALMKYHILN
Be
ta
M
er
ge
d
M
em
br
an
e
DA
PI
Al
ph
a
Alpha 6 Alpha v
Alpha 6 Alpha 3Alpha 3 Alpha 2 Alpha 5
Beta 1 Beta 1 Beta 1 Beta 1 Beta 1 Beta 1 Beta 1 Beta 1 Beta 1Beta 4
Alpha 1 Alpha 9 Alpha 1
scale bar: 25um
Beta1 alpha5 alpha6alpha3alpha2 alphav
M
em
br
an
e
DA
PI
In
te
gr
in 
Su
bu
nit Beta 1 alpha2 alpha 3 alpha 5 alpha 6 alpha v
scale bar: 25um
3D
 E
nc
ap
su
lat
ion
 in
 P
EG
 o
nly
 fo
r 5
 m
inu
te
s
3D
 e
nc
ap
su
lat
ion
 fo
r 5
 m
inu
te
s
a
b
  
Figure S5. Optimization of human primary astrocytes seeding density in the brain hydrogel. a) Human 
primary astrocytes were encapsulated at a density of 1,000-, 3,000-, 5,000-, and 8,000 cells/gel (10uL) in 
the brain hydrogel and cultured for a period of 7 days. b) Cells can also be encapsulated at greater densities 
(e.g. 500,000 cell/gel), which results in undesired astrocyte network formation. 
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Figure S6. Human primary astrocytes extend processes through networks with each MMP-degradable 
domain. Representative images of human astrocytes encapsulated in a functionalized brain hydrogel, 
hydrogels with a single MMP-degradable peptide and an integrin-binding peptide concentration of 2mM, or 
a non-degradable PEG hydrogel for a period of 14 days. Scale bars for large images = 200um, and 50um 
for insets. 
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Figure S7. Optimization of MMP-degradable peptide concentration in the brain hydrogel. a) Human 
astrocytes were encapsulated in collagen gels, or brain hydrogels with 6-,13-, and 25-mol% MMP-
degradable peptide mixtures, while integrin-binding peptides were kept constant at 2mM. Representative 
images of cell morphology and dynamic remodeling of the hydrogel for a period of 7 days. b) Representative 
images of astrocyte cell morphology after 72 hours of encapsulation. c) Quantification of the distance from 
the cell center over time for hydrogels at different conditions as compared to a non-degradable PEG 
hydrogel. Astrocytes encapsulated in a brain hydrogel with 13mol% and 25mol% MMP-specific peptide 
mixture achieve a longer extension similar to collagen cultured astrocytes. d) Cell diameter of astrocytes 
cultured in brain hydrogels at different conditions, and collagen for 72 hours. Data shown is mean + s.d. 
N=3, n=4.  
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Figure S8. Astrocyte activation is regulated by tuning of integrin binding and MMP-degradable peptides in 
the brain hydrogel. Representative images of astrocytes stained for gfap (green), membrane (red) and DAPI 
(blue) at different formulations of the brain hydrogel as compared to collagen. The concentration of integrin-
binding peptides was kept constant at 2mM in columns 1 and 2, and 4mM in columns 3 and 4. 
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Figure S9. Astrocytes are activated with cytokine dosing in the brain hydrogel. Representative images of 
astrocytes encapsulated in collagen or brain hydrogel in the presence of control medium (C), quiescent 
medium (Q), or cytokine-dosed conditions with either a normal concentration (+), or double (++).  
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Figure S10. Human primary astrocytes become activated to small molecular weight hyaluronic acid in a 
dose-dependent manner. a) Normalized GFAP fluorescence increases with increasing concentration of 
hyaluronate thiol in the brain hydrogel. Data shown are mean and s.e.m. N=2, n=3. b) Distance from the 
cell center for astrocytes encapsulated in hyaluronate thiol modified brain hydrogels for 48 hours. Process 
length decreases with increasing concentration of HA. Data shown are mean and s.e.m. N=2, n=3. c) 
Representative bright field images of astrocytes encapsulated in hyaluronate thiol modified brain hydrogels 
for a period of 48 hours. Scale bars = 30um. 
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